|
LEXX Lexaria Bioscience Corp 1348362 |
| Income Statement |
|
Revenue
|
lxrp_10q
|
183,923 |
|
Net Income
|
lxrp_10q
|
-2,703,699 |
|
Profit Margin
|
|
-1470.02% |
| Balance Sheet |
|
Current Assets
|
8,825,741 |
|
Assets
|
9,793,774 |
|
Current Liabilities
|
297,798 |
|
Liabilities
|
399,718 |
|
Equity
|
9,394,056 |
|
Shares Out
|
15,810,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,726,045 |
|
Investing Cash Flow
|
-37,804 |
| Market Analysis |
Market Cap
|
51,699,353 |
|
Price
|
1.49 |
|
BVPS
|
0.59 |
|
PB
|
2.49 |
|
EPS
|
-0.45 |
|
PS
|
70.27 |
|
FCF
|
-2,763,849 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LEXX documents filed with the SEC.
LEXX Filings
Clear
